Patient-Derived Organoid Biobanks for Translational Research and Precision Medicine: Challenges and Future Perspectives
Journal of Personalized Medicine · 21.08.2025 · 15 (8) · 394
DOI: 10.3390/jpm15080394 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Personalized Medicine, online erschienen am 21.08.2025. Verfasst von Floriana Jessica Di Paola und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biobank of Research, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Italian Ministry of University and Research (MUR) PRIN project, Italian Ministry of University and Research (MUR) PRIN project.
Abstract (Originalsprache)
Over the past decade, patient-derived organoids (PDOs) have emerged as powerful in vitro models that closely recapitulate the histological, genetic, and functional features of their parental primary tissues, representing a ground-breaking tool for cancer research and precision medicine. This advancement has led to the development of living PDO biobanks, collections of organoids derived from a wide range of tumor types and patient populations, which serve as essential platforms for drug screening, biomarker discovery, and functional genomics. The classification and global distribution of these biobanks reflect a growing international effort to standardize protocols and broaden accessibility, supporting both basic and translational research. While their relevance to personalized medicine is increasingly recognized, the establishment and maintenance of PDO biobanks remain technically demanding, particularly in terms of optimizing long-term culture conditions, preserving sample viability, and mimicking the tumor microenvironment. In this context, this review provides an overview of the classification and worldwide distribution of tumor and paired healthy tissue-specific PDO biobanks, explores their translational applications, highlights recent advances in culture systems and media formulations, and discusses current challenges and future perspectives for their integration into clinical practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biobank of Research, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
- Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40138 Bologna, Italy.
- Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
ORCID-Profile: Floriana Jessica Di Paola, Giulia Calafato, Pier Paolo Piccaluga, Giovanni Tallini, Kerry Jane Rhoden
Förderung
- The Italian Ministry of University and Research (MUR) PRIN project
- Italian Ministry of University and Research (MUR) PRIN project
Zitieren
APA
Di Paola, F. J., Calafato, G., Piccaluga, P. P., Tallini, G., & Rhoden, K. J. (2025). Patient-Derived Organoid Biobanks for Translational Research and Precision Medicine: Challenges and Future Perspectives. Journal of Personalized Medicine, 15(8), 394. https://doi.org/10.3390/jpm15080394
Vancouver
Di Paola FJ, Calafato G, Piccaluga PP, Tallini G, Rhoden KJ. Patient-Derived Organoid Biobanks for Translational Research and Precision Medicine: Challenges and Future Perspectives. Journal of Personalized Medicine. 2025;15(8):394. doi:10.3390/jpm15080394
BibTeX
@article{DiPaola2025,
author = {Di Paola, Floriana Jessica and Calafato, Giulia and Piccaluga, Pier Paolo and Tallini, Giovanni and Rhoden, Kerry Jane},
title = {Patient-Derived Organoid Biobanks for Translational Research and Precision Medicine: Challenges and Future Perspectives},
journal = {Journal of Personalized Medicine},
year = {2025},
volume = {15},
number = {8},
pages = {394},
doi = {10.3390/jpm15080394}
}
EUVIMED